Nationwide Fund Advisors purchases $26.4M Zimmer Biomet stake: 5 key notes

Nationwide Fund Advisors purchased stake in Zimmer Biomet, according to a Financial Market News report.

Advertisement

Here are five key notes on the purchase:

 

1. Nationwide Fund Advisors bought 258,212 shares of Zimmer Biomet stock during the fourth quarter of 2015.

 

2. The company’s share purchase is valued at $26.4 million and Nationwide now owns around 0.13 percent of Zimmer Biomet.

 

3. Security Nation Trust also acquired Zimmer Biomet shares in the last quarter, valued at $1.6 million. Speece Thorson Capital Group purchased new stake in Zimmer Biomet as well, valued at round $7.6 million.

 

4. Zimmer Biomet reported earning $1.98 billion during the fourth quarter of 2015, up from the analysts’ expected $1.96 billion. Quarterly revenue was up 58.1 percent over the same period last year.

 

5. Zimmer Biomet’s 50-day moving average stock price is $97.26 and the one-year high is $121.54. The one-year low is $99.97 and the market cap is $19.8 billion.

 

More articles on orthopedic devices:
6 things to know about Johnson & Johnson’s stock: Is there long-term strength?
European spine surgery devices market to reach $3B—3 takeaways
United Orthopedic Corporation to enroll patients in THA study: 5 notes

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.